Nobel Prize in Medicine 2018 awarded for the development of new cancer therapies with checkpoint inhibitors
/in IOZK announcements, Other announcements /by rootIOZK presentation on the effects of multi-modal immunotherapy in a pontine glioma with the aid of liquid biopsy analysis
/in IOZK at conferences, Other announcements /by rootImmunotherapy for prostate cancer: Canadian research group presents the current situation
/in IOZK in the press, Other announcements /by IOZK
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Cologne | Germany
T: +49 (0)221 – 420 399 25
F: +49(0)221 - 420 399 26
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Cologne | Germany
T: +49 (0)221 – 420 399 25
F: +49(0)221 - 420 399 26
E-Mail: info@iozk.de
The IOZK Immunotherapy
News
- Award for groundbreaking discovery in immunotherapy goes to Prof. Shimon Sakaguchi
- Symposium and Training at the IOZK: Immunotherapy in Neuro-Oncology, Friday, September 6, 2019
- Professor Volker Schirrmacher from the IOZK opened the Symposium on Tumor Immunology at Kiel University with a talk about research on oncolytic viruses in conjunction with a personalized immunotherapy for cancer.